Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

Chetan S Karyekar, Shoba Ravichandran, Elsie Allen, Douglas Fleming, Robert Frederich Bristol-Myers Squibb, Princeton, NJ, USA Purpose: To assess safety and efficacy of saxagliptin in older patients with type 2 diabetes mellitus (T2DM). Patients and methods: This was a post hoc analysis of pooled d...

Full description

Bibliographic Details
Main Authors: Karyekar CS, Ravichandran S, Allen E, Fleming D, Frederich R
Format: Article
Language:English
Published: Dove Medical Press 2013-04-01
Series:Clinical Interventions in Aging
Subjects:
clinical trial
dipeptidyl peptidase-4
DPP-4 inhibitor
hypoglycemia
metformin
Online Access:https://www.dovepress.com/tolerability-and-efficacy-of-glycemic-control-with-saxagliptin-in-olde-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/tolerability-and-efficacy-of-glycemic-control-with-saxagliptin-in-olde-peer-reviewed-article-CIA

Similar Items